We are live on ! Find out more
MYOK

MyoKardia, Inc. Common Stock
MYOK

Delisted

MYOK was delisted on the 16th of November, 2020.

Back to rankings

115 hedge funds and large institutions have $974M invested in MyoKardia, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

444% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 9

371% more capital invested

Capital invested by funds: $207M → $974M (+$767M)

81% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 21

53% more funds holding

Funds holding: 75 → 115 (+40)

Holders
115
Holders Change
+40
Holders Change %
+53.33%
% of All Funds
2.87%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.22%
New
49
Increased
38
Reduced
21
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$34.6M
2
EC
EcoR1 Capital
California
+$22M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$21.6M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$18.8M
5
BlackRock
BlackRock
New York
+$17.4M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$16.1M
2
JP Morgan Chase
JP Morgan Chase
New York
-$10M
3
Millennium Management
Millennium Management
New York
-$7.12M
4
MWNA
Marshall Wace North America
New York
-$4.46M
5
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$2.75M
Name Holding Trade Value Shares
Change 		Change in
Stake
IUHSA
101
Itau Unibanco Holding S.A.
Brazil
$85K -$48.5K -1,521 -71%
Bank of America
102
Bank of America
North Carolina
$81K +$46.2K +1,449 +321%
BNP Paribas Financial Markets
103
BNP Paribas Financial Markets
France
$75.9K -$3.13K -98 -5%
Canada Life
104
Canada Life
Manitoba, Canada
$72K – – –
Royal Bank of Canada
105
Royal Bank of Canada
Ontario, Canada
$66K +$47.8K +1,499 +3,945%
AIP
106
Ameritas Investment Partners
Nebraska
$65K – – –
FPFS
107
First Personal Financial Services
North Carolina
$38K – – –
Russell Investments Group
108
Russell Investments Group
United Kingdom
$35K +$26.2K +822 New
Citigroup
109
Citigroup
New York
$32K -$65.1K -2,040 -73%
TRCT
110
Tower Research Capital (TRC)
New York
$24K +$14.5K +454 +454%
MA
111
MUFG Americas
New York
$15K +$11.3K +353 New
MAM
112
Meeder Asset Management
Ohio
$10K -$1.31K -41 -15%
CHP
113
Cable Hill Partners
Oregon
$6K -$11.2K -350 -70%
Federated Hermes
114
Federated Hermes
Pennsylvania
$1K +$351 +11 New
PHK
115
Point72 Hong Kong
Hong Kong
$1K +$638 +20 New
Millennium Management
116
Millennium Management
New York
– -$7.12M -543,697 Closed
Hudson Bay Capital Management
117
Hudson Bay Capital Management
Connecticut
– -$2.75M -210,000 Closed
TC
118
TFS Capital
Pennsylvania
– -$467K -35,615 Closed
HHC
119
Hutchin Hill Capital
New York
– -$410K -31,300 Closed
SIM
120
Spark Investment Management
New York
– -$408K -31,200 Closed
TI
121
Trexquant Investment
Connecticut
– -$172K -13,100 Closed
DSI
122
Daiwa SB Investments
Japan
– -$82K -6,240 Closed
Creative Planning
123
Creative Planning
Kansas
– -$26K -2,000 Closed
AIM
124
Acrospire Investment Management
Illinois
– -$7K -506 Closed
1 2 3 4
5

MYOK Hedge Fund Activity: Q3 2017 in Review

115 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q3 2017, worth a combined $974M — up 371% from $207M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new MYOK positions and 9 closed out — a net gain of 40 holders — while 38 added to existing stakes and 21 trimmed.

The largest buyer was Deerfield Management, adding an estimated $34.6M. The largest seller was Fidelity Investments, cutting an estimated $16.1M.

  • 115 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q3 2017, up from 75 in Q2 2017.
  • Funds reported $974M of MyoKardia, Inc. Common Stock stock for Q3 2017, up 371% quarter-over-quarter.
  • 49 funds opened new MyoKardia, Inc. Common Stock positions in Q3 2017 and 9 closed out, a net change of +40 holders.
  • The largest MyoKardia, Inc. Common Stock buyer in Q3 2017 was Deerfield Management, an estimated $34.6M added.
  • The largest MyoKardia, Inc. Common Stock seller in Q3 2017 was Fidelity Investments, an estimated $16.1M sold.

Based on aggregated 13F filings for Q3 2017.